| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355694A Measalazine controlled redease oral pharmaceutical compositions |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355691A Antibody and polyalkylene glycol-bonded liposome |
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/26/2002 | CN1086590C Eye drops contg. sodium hyaluronate and preparing method thereof |
| 06/26/2002 | CN1086589C Vaccines |
| 06/26/2002 | CN1086579C Oral formulations of antifungal |
| 06/26/2002 | CN1086575C New stable medicinal compositions for generating propellant-free aerosols |
| 06/25/2002 | US6410761 Purification by isomerization, distillation |
| 06/25/2002 | US6410695 Individual medicament dosing conjugate |
| 06/25/2002 | US6410680 Dendrimer constructs and metal complexes thereof having superoxide dismutase activity |
| 06/25/2002 | US6410645 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 06/25/2002 | US6410599 Mixture of benzalkonium chloride, water and isopropanol |
| 06/25/2002 | US6410575 Administering (5-aryl-1,2,4-thiadiazol)-3-yl thiourea and urea derivatives to treat hepatitis, hiv and kaposi sarcoma, as viricides and anticarcinogenic agents |
| 06/25/2002 | US6410517 Targeted gene delivery system |
| 06/25/2002 | US6410514 Tissue specific prodrug |
| 06/25/2002 | US6410513 Polypeptides |
| 06/25/2002 | US6410511 Formulations for amylin agonist peptides |
| 06/25/2002 | US6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 06/25/2002 | US6410250 Sustained delivery device and methods of making and using the same |
| 06/25/2002 | US6410057 Biodegradable mixed polymeric micelles for drug delivery |
| 06/25/2002 | US6410055 Spherical pharmaceutical granules comprising microcrystalline cellulose and a process for their production |
| 06/25/2002 | US6410054 Immediate release eplerenone compositions |
| 06/25/2002 | US6410053 Reversible cross-linked gel |
| 06/25/2002 | US6410049 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
| 06/25/2002 | US6410048 Prolamin-plant polar lipid combination, preparation method and applications |
| 06/25/2002 | US6410045 Drug delivery system for antiglaucomatous medication |
| 06/25/2002 | US6410036 Liquid, substantially anhydrous eutectic mixture comprising principal acid component and another component selected from carbohydrates, polyols, carbonylic compounds, amino acids and carboxylic acids |
| 06/25/2002 | US6410034 Agent consisting essentially of p-menthane-3,8-diol and 3-l-menthoxypropane-1,2-diol |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410009 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 06/25/2002 | US6410004 Polyureas and water-soluble or water-dispersible polymeric salts |
| 06/25/2002 | US6409990 Backbone comprising dextran having affixed thereto a plurality of groups having amino-alkyl-thio-alkyl-ether structure |
| 06/25/2002 | CA2208351C Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 06/25/2002 | CA2188596C Non-separable starch-oil compositions |
| 06/25/2002 | CA2144675C Acylated y-cyclodextrins |
| 06/25/2002 | CA2140281C Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/25/2002 | CA2101245C Dosage forms comprising polymers comprising different molecular weights |
| 06/20/2002 | WO2002048380A2 Glycosilated cationic lipids for liposomes used in drug delivery |
| 06/20/2002 | WO2002048377A2 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof |
| 06/20/2002 | WO2002048372A2 Target enzymes |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048170A1 Lipids comprising an aminoxy group |
| 06/20/2002 | WO2002048116A2 Inhibitors of hepatitis c virus ns3 protease |
| 06/20/2002 | WO2002048110A2 Composition for regulating animal growth, method of manufacture and use thereof |
| 06/20/2002 | WO2002047731A2 Drug delivery compositions and coated medical devices |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047729A2 Drug delivery system comprising a drug intercalated between a layered double hidroxide |
| 06/20/2002 | WO2002047728A2 Treatment of posterior capsule opacification |
| 06/20/2002 | WO2002047727A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | WO2002047726A2 Pharmaceutical composition containing an active with a hemolytic action and a surfactant |
| 06/20/2002 | WO2002047725A2 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
| 06/20/2002 | WO2002047724A2 Coupling agent for introducing sound waves into the human body while reducing the amount of pain incurred |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002047717A2 Targeted enzyme prodrug therapy |
| 06/20/2002 | WO2002047704A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | WO2002047694A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | WO2002047693A2 Steroid hormone products comprising a stabilizing agent in non-crystalline form |
| 06/20/2002 | WO2002047692A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 06/20/2002 | WO2002047685A2 Nmda receptor agonist pharmaceutical compositions |
| 06/20/2002 | WO2002047668A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 06/20/2002 | WO2002047667A2 Novel medicament compositions based on anticholinesterase drugs and on a steroid |
| 06/20/2002 | WO2002047664A2 Microparticles with an improved release profile and method for the production thereof |
| 06/20/2002 | WO2002047663A1 Self emulsifying lipid matrix (selm) |
| 06/20/2002 | WO2002047661A1 Pharmaceutical composition for intramuscular injection containing loxoprofen |
| 06/20/2002 | WO2002047660A1 Pharmaceutical dronedarone composition for parenteral administration |
| 06/20/2002 | WO2002047659A2 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 06/20/2002 | WO2002047643A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 06/20/2002 | WO2002047642A1 Hypoallergenic and non-irritant skin care formulations |
| 06/20/2002 | WO2002047615A2 Oral compositions and use thereof |
| 06/20/2002 | WO2002032375A3 Uses of monoclonal antibody 8h9 |
| 06/20/2002 | WO2002013869A3 Flavone-containing plant extract solutions having improved storage and heat stability |
| 06/20/2002 | WO2002011669A3 Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof |
| 06/20/2002 | WO2002005800A8 Compositions for sustained release of analgesic agents, and methods of making and using the same |
| 06/20/2002 | WO2002002145A3 Composition for aqueous stabilization of fat-soluble vitamins |
| 06/20/2002 | WO2002002085A3 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 06/20/2002 | WO2001097774A3 Novel pharmaceutical composition for the topical application of water-insoluble and/or hardly water-soluble active agents |
| 06/20/2002 | WO2001091797A3 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 06/20/2002 | WO2001087264A3 Rapidly disintegrating solid oral dosage form |
| 06/20/2002 | WO2001062298A3 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 06/20/2002 | WO2001027154A3 Membrane translocating peptide drug delivery system |
| 06/20/2002 | WO2001009165A8 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 06/20/2002 | WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof |
| 06/20/2002 | WO2000056774A9 Methods of using bioelastomers |
| 06/20/2002 | US20020077676 Implantable device and method for the electrical treatment of cancer |
| 06/20/2002 | US20020077461 Pharmaceutical formulation |
| 06/20/2002 | US20020077454 Therapeutic pore-forming peptides |
| 06/20/2002 | US20020077437 For administering a therapeutic agent to a patient |
| 06/20/2002 | US20020077364 Thyroid hormone formulations |
| 06/20/2002 | US20020077334 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/20/2002 | US20020077314 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 06/20/2002 | US20020077304 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 06/20/2002 | US20020077303 For therapy of human and animal tumors |
| 06/20/2002 | US20020077294 Method of treating blood disorders |
| 06/20/2002 | US20020077290 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 06/20/2002 | US20020077280 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 06/20/2002 | US20020077279 Manufacture of polyglutamate-therapeutic agent conjugates |